Table. Summary of antiviral therapy received by immunocompromised patient with mpox, California, USA, 2022.
| Antiviral therapy | Dose | Days administered* |
|---|---|---|
| Tecovirimat | 200 mg orally twice daily | 0–14, 56–125 |
| Cidofovir | 5 mg/kg intravenously weekly | 89, 96 |
| Brincidofovir | 200 mg orally weekly | 103, 111, 117, 124, 132, 140 |
| Vaccinia immune globulin | 576,000 units intravenously | 92 |
*Day 0 was the date the patient first sought care at an urgent care clinic.